Merus publications
Web28 jan. 2024 · Search strategy and selection criteria. The electronic databases PubMed and Google Scholar were searched for articles documenting An. merus using the search phrases “Anopheles merus” and “saltwater Anopheles gambiae”. All the documents were screened and assessed to determine whether they had any data on vector densities, … Web24 rijen · 17 aug. 2024 · Clinical activity of MCLA-128 (zenocutuzumab), trastuzumab and …
Merus publications
Did you know?
Web5 uur geleden · Contact Data Investor and Media Inquiries: Sherri Spear Merus N.V. VP Investor Relations and Corporate Communications 617-821-3246 Kathleen Farren … Web14 apr. 2024 · UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 14, 2024 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or …
Web14 mrt. 2024 · UTRECHT, The Netherlands and CAMBRIDGE, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics ® and Triclonics ®), today announced the publication of an abstract … Web14 apr. 2024 · Merus Announces Publication of an Abstract on Petosemtamab Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma for Plenary Session Oral Presentation at the AACR Annual Meeting 2024 and Provides a Program and Regulatory Update Published: Apr 14, 2024 - Robust 36% overall response rate (ORR) …
WebMCLA-129 reverses resistance to tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC) cell lines and inhibits tumor growth in xenograft models of NSCLC. Merus has … Web3 apr. 2024 · Merus Announces Publication of an Abstract on Preclinical Mechanism of Action of MCLA-129 Selected for Poster Presentation at the AACR Annual Meeting 2024. Poster presentation: Tuesday, April 18, 2024, 1:30-5:30 p.m. ET Poster presentation: Tuesday, April 18, 2024, 1:30-5:30 p.m. ET
Web5 uur geleden · Investor and Media Inquiries: Sherri Spear Merus N.V. VP Investor Relations and Corporate Communications 617-821-3246 [email protected] Kathleen Farren Merus N.V. IR/Corp Comms 617-230-4165 k ...
WebMerus Multiclonics. Our Multiclonics ® therapeutics are produced from our proprietary technology platforms, which are able to generate a diverse array of antibody binding … cost to build a business websiteWeb12 okt. 2024 · Contact Data Investor and Media Inquiries: Sherri Spear Merus N.V. VP Investor Relations and Corporate Communications 617-821-3246 Kathleen Farren Merus N.V. IR/Corp Comms 617-230-4165 cost to build a brick buildingWeb10 apr. 2024 · Merus N.V. Announces Publication of Abstract on MCLA-129 At the American Association for Cancer Research 2024 Annual Meeting. Mar 10. Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Mar 04. New Forecasts: Here's What Analysts Think The Future Holds For Merus N.V. … cost to build a campgroundWebInvestegate announcements from Merus N.V., Merus Announces Publication of an Abstract on Petosemtamab Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma for Plenary Session Oral Presentation at the AACR Annual Meeting 2024 and Provides a Program and Regulatory Update cost to build a carport 14x20x7Web5 uur geleden · UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 14, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing... breast cellWeb5 jun. 2024 · Contact Data Investor and Media Inquiries: Sherri Spear Merus N.V. VP Investor Relations and Corporate Communications 617-821-3246 Kathleen Farren Merus N.V. IR/Corp Comms 617-230-4165 breast center 109 st edmontonWeb14 feb. 2013 · Anopheles merus, a sibling species of ... We performed a literature review from PubMed and Google Scholar and reviewed over 50 publications relating to An. merus 's bionomics, taxonomy, ... breast center annapolis md